PerspectiveBiomedicine

Avoiding Collateral Damage in Alzheimer's Disease Treatment

See allHide authors and affiliations

Science  27 Oct 2006:
Vol. 314, Issue 5799, pp. 602-603
DOI: 10.1126/science.1135043

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

Although-secretase has been considered a relatively harmless target for drugs against Alzheimer's disease, such drugs may damage nearby nerves.